Medicare Enrolled
Dr. Jason Boutros, M.D.
Optician · Pasadena, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Boutros from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Boutros?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Boutros
Dr. Jason Boutros is an optician specialist in Pasadena, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Boutros performed 7,747 Medicare services across 2,376 unique beneficiaries.
Between the years covered by Open Payments, Dr. Boutros received a total of $18,377 from 71 pharmaceutical and/or device companies across 1086 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Boutros is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 11% volume in CA
$18,377 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,747
Medicare services
Top 11% in CA for optician
2,376
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~408 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,904 | $84 | $125 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,703 | $62 | $80 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,363 | $70 | $100 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
391 | $4 | $20 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
374 | $7 | $45 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
372 | $13 | $85 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
285 | $8 | $15 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
274 | $176 | $285 |
| Annual depression screening | 233 | $21 | $25 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
219 | $140 | $170 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
119 | $45 | $125 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
116 | $11 | $50 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
92 | $0 | $28 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
57 | $145 | $250 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
56 | $96 | $125 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
55 | $35 | $100 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
35 | $38 | $74 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
34 | $1 | $15 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
20 | $3 | $35 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
18 | $9 | $85 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $46 | $75 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $82 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$18,377
Total received (2018-2024)
Avg $2,625/year across 7 years
Top 9% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
1,086
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,141 (93.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,236 (6.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,964
2023
$1,825
2022
$2,270
2021
$3,825
2020
$2,477
2019
$2,296
2018
$3,721
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$386
Phathom Pharmaceuticals, Inc.
$357
Boehringer Ingelheim Pharmaceuticals, Inc.
$211
ABBVIE INC.
$197
Bayer Healthcare Pharmaceuticals Inc.
$109
Novo Nordisk Inc
$109
Otsuka America Pharmaceutical, Inc.
$75
Axsome Therapeutics, Inc.
$65
Abbott Laboratories
$63
Lundbeck LLC
$59
E.R. Squibb & Sons, L.L.C.
$52
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$46
IRONWOOD PHARMACEUTICALS, INC
$43
Sumitomo Pharma America, Inc.
$40
Ardelyx, Inc.
$32
Almatica Pharma LLC
$28
ANI Pharmaceuticals, Inc.
$28
SCILEX PHARMACEUTICALS INC.
$22
Corcept Therapeutics
$21
Amgen Inc.
$19
Top 3 companies account for 48.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$3,284
Biohaven Pharmaceuticals, Inc.
$1,236
Boehringer Ingelheim Pharmaceuticals, Inc.
$949
AbbVie Inc.
$926
Lilly USA, LLC
$878
SANOFI-AVENTIS U.S. LLC
$838
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$780
Novo Nordisk Inc
$725
Janssen Pharmaceuticals, Inc
$670
ABBVIE INC.
$623
Merck Sharp & Dohme Corporation
$608
Horizon Therapeutics plc
$520
Allergan Inc.
$420
E.R. Squibb & Sons, L.L.C.
$410
Kowa Pharmaceuticals America, Inc.
$409
Phathom Pharmaceuticals, Inc.
$357
Sumitomo Pharma America, Inc.
$317
Ironwood Pharmaceuticals, Inc
$315
Teva Pharmaceuticals USA, Inc.
$280
Allergan, Inc.
$251
Bayer Healthcare Pharmaceuticals Inc.
$247
RedHill Biopharma Inc.
$237
Circassia Pharmaceuticals Inc
$220
Bayer HealthCare Pharmaceuticals Inc.
$212
Abbott Laboratories
$178
Assertio Therapeutics, Inc.
$169
Hikma Pharmaceuticals USA
$169
Otsuka America Pharmaceutical, Inc.
$141
Daiichi Sankyo Inc.
$139
Nestle HealthCare Nutrition Inc.
$132
Amgen Inc.
$129
IRONWOOD PHARMACEUTICALS, INC
$125
Sunovion Pharmaceuticals Inc.
$97
Lundbeck LLC
$91
Corium, LLC
$74
Astellas Pharma US Inc
$70
Biogen, Inc.
$67
Merck Sharp & Dohme LLC
$65
Axsome Therapeutics, Inc.
$65
Alkermes, Inc.
$61
Almatica Pharma LLC
$56
Scilex Pharmaceuticals Inc.
$52
West-Ward Pharmaceuticals
$50
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$46
IDORSIA PHARMACEUTICALS US INC
$43
Eyevance Pharmaceuticals LLC
$41
SCILEX PHARMACEUTICALS INC.
$38
MannKind Corporation
$35
ARALEZ PHARMACEUTICALS US INC.
$34
Takeda Pharmaceuticals U.S.A., Inc.
$34
Mannkind Corporation
$33
Ardelyx, Inc.
$32
Eisai Inc.
$32
Philips Electronics North America Corporation
$31
Gilead Sciences, Inc.
$30
UCB, Inc.
$29
ANI Pharmaceuticals, Inc.
$28
Biohaven Pharmaceutical Holding Company Ltd.
$24
Medtronic MiniMed, Inc.
$24
Dexcom, Inc.
$22
Corcept Therapeutics
$21
Becton, Dickinson and Company
$20
Mission Pharmacal Company
$20
Avanir Pharmaceuticals, Inc.
$19
Ferring Pharmaceuticals Inc.
$18
Synergy Pharmaceuticals Inc
$17
ALK-Abello, Inc
$17
Smith & Nephew, Inc.
$13
EISAI INC.
$13
Novum Pharma, LLC
$12
Upsher-Smith Laboratories LLC
$12
Top 3 companies account for 29.8% of all-time payments
Associated products mentioned in payments ›
ADLARITY · ADUHELM · AFREZZA · AJOVY · APRISO · ARISTADA · AUSTEDO · Adlarity · Aemcolo · Aimovig · Alcortin A · Austedo XR · Auvelity · BAQSIMI · BASAGLAR · BD Nano · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · Binosto · Briviact · CAMZYOS · CAPLYTA · COBENFY · CREON · Cambia · DUAKLIR PRESSAIR · DUEXIS · DUZALLO · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · EUFLEXXA · FARXIGA · FASENRA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GEMTESA · Gralise · IBSRELA · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · Korlym · LASTACAFT · LATUDA · LINZESS · LIVALO · LOKELMA · LOREEV XR · LYBALVI · Linzess · Livalo · MOTEGRITY · MOUNJARO · MOVANTIK · MYRBETRIQ · Minimed 670G System · Mitigare · Morphabond ER · Movantik · NAPRELAN · NURTEC ODT · Nuedexta · Odactra · Ozempic · PENNSAID · PURIFIED CORTROPHIN GEL · ProAir Digihaler · Prolia · QULIPTA · QUVIVIQ · QVAR · RAYOS · RELISTOR · RELISTOR ORAL · REXULTI · Respiratoriy Care Undiv · Ryaltris · Rybelsus · SOLIQUA · SOLIQUA 100/33 · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · Santyl · Saxenda · Seglentis · TOSYMRA SUMATRIPTAN NASAL SPRAY · TOUJEO · TRADJENTA · TRULANCE · TRULICITY · TUDORZA PRESSAIR · Talicia · Tobradex ST · Tresiba · Trulance · UBRELVY · UTIBRON · VIBERZI · VOQUEZNA · VRAYLAR · Victoza · XARELTO · XIFAXAN · XIFIXAN · ZENPEP · ZONTIVITY · ZTLido · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for optician in CA.
Geographic Context
Opticians within 10 mi
1,448
Per 100K population
14.7
County median income
$87,760
Nearest hospital
AURORA LAS ENCINAS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Boutros is a clinical cardiology specialist, with above-average Medicare volume (top 11% in CA), with low-engagement industry engagement in the top 9% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Boutros experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Boutros performed 1,904 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Boutros receive payments from pharmaceutical companies?
Yes. Dr. Boutros received a total of $18,377 from 71 companies across 1,086 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Boutros's costs compare to other opticians in Pasadena?
Dr. Boutros's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Boutros) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Pasadena
Browse opticians in Pasadena ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology